2024-12-31-accounts - The Clinical Genetics Society

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

	Trustees' Annual Report for the period Period start date To Period end date 1st January 2024 31st Decembe r 2024	Trustees' Annual Report for the period Period start date To Period end date 1st January 2024 31st Decembe r 2024	Trustees' Annual Report for the period Period start date To Period end date 1st January 2024 31st Decembe r 2024	Trustees' Annual Report for the period Period start date To Period end date 1st January 2024 31st Decembe r 2024	Trustees' Annual Report for the period Period start date To Period end date 1st January 2024 31st Decembe r 2024	Trustees' Annual Report for the period Period start date To Period end date 1st January 2024 31st Decembe r 2024	Trustees' Annual Report for the period Period start date To Period end date 1st January 2024 31st Decembe r 2024
	Trustees' Annual Report for the period
From	Period start date			To	Period end date
	1st	January	2024		31st	Decembe r	2024
Reference and administration details

Charity name Clinical Genetics Society

Other names charity is known by

CGS

Registered charity number (if any)

Charity's principal address

c/o Britsh Societyof Genetc Medicine	c/o Britsh Societyof Genetc Medicine
1 Naoroji Street Islington
LONDON
Postcode	WC1X 0GB

Names of the charity trustees who manage the charity

	Trustee name	Office (if any)	Dates acted if not for whole year
1.	Dr Mohnish Suri	President
2.	Professor Diana Baralle	Outgoing President
3.	Dr Meena Balasubramanium	Academic Secretary
4.	Dr Sarah Bowdin	Secretary
5.	Dr Ian Ellis	Treasurer	From 1stJanuary2025
6.
7.
8.
9.
10.
11.
12.

TAR

May 2016

Names of the trustees for the charity, if any, (for example, any custodian trustees)

Names of the trustees for the charity, if	any, (for example, any custodian trustees)
Name	Dates acted if not for whole year
Dr Emma Wakeling	1stJanuary 2024 - 31stDecember 2024,l and then stood down

Names and addresses of advisers (Optional information)

Type of adviser	Name Address	Name Address
Fellow Association of Charity Independent Examiners	Rev'd. Alan A. Clements	15 Carleton Road, Great Knowley, Chorley PR6 8TQ

Name of chief executive or names of senior staff members (Optional information)

Section B Structure, governance and management Description of the charity’s trusts

Type of governing document Constitution (eg. trust deed, constitution) How the charity is constituted Association (eg. trust, association, company) Trustee selection methods By selection / election (eg. appointed by, elected by)

TAR

May 2016

Additional governance issues (Optional information) You may choose to include additional information, where relevant, about:

Call for members to apply to a Trustee post, selection by exiting Trustees and voting by member election if required

policies and procedures adopted for the induction and training of trustees;
the charity’s organisational structure and any wider network with which the charity works;
relationship with any related parties;
trustees’ consideration of major risks and the system and procedures to manage them.

Section C Objectives and activities

Summary of the objects of the charity set out in its governing document Summary of the main activities undertaken for the public benefit in relation to these objects (include within this section the statutory declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)	To advance and promote the science and medical practce of Clinical Genetcs. For this purpose only it will bring together persons who have a common interest in Clinical Genetcs, so that they may be aided in their joint endeavours to diagnose, understand, prevent, alleviate and cure congenital malformatons and conditons with a genetc aetology. In furtherance of these aims, but not ~~otherwise the Society may publish and disseminate~~
	~~,~~ reports,statements,and research fndings. Holding conferences and educational meetings.

TAR

May 2016

Additonal details of objectves and actvites (Optonal informaton) You may choose to include further statements, where relevant, about:

policy on grantmaking;

TAR

May 2016

Section D Achievements and performance

Summary of the main Holding of a joint educational and scientific meeting, in

achievements of the collaboration with the Cancer Genetics Group (CGG). charity during the year Representing the interests of its members in national, health service and related governmental working parties on policies related to Clinical Genetics. Publishingh a report surveying the training pathway and career interests of Registrars and Academic Fellows training in Clinical Genetics.

TAR

May 2016

Section E Financial review

We currently have a bank balance in excess of £90,000 and Brief statement of the feel that we need a working reserve of over £60,000 to charity’s policy on reserves protect the interests of the society. Details of any funds materially in deficit

We are currently looking at a number of projects that will help us to invest these funds on behalf of the interests of Further financial review our members. details (Optional information)

You may choose to include additional information, where relevant about:

the charity’s principal sources of funds (including any fundraising);
how expenditure has supported the key objectives of the charity;
investment policy and objectives including any

ethical investment policy adopted.

Section F Other optional information

Section G Declaration

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees

Signature(s)

Full name(s)

Ian Harold ELLIS

TAR

May 2016

Position (eg Secretary, Chair, etc)

Treasurer

Date. 28[th] March 2025

TAR

May 2016

Clinical Genetics Society	Clinical Genetics Society	Clinical Genetics Society	274959	CC16a
Receipts andpayments accounts
For the period from	1st January 2024	To	2024 31st December

Section A Receipts and payments	Section A Receipts and payments
A1 Receipts Section A Receipts and payments Subscriptions In from BSGM 730 Conefrence Registration Fees from BSGM 62,570 Conference Sponsors 8,866 Other Income 765 Payment byBSGM 8,440 81,371 Sub total Total receipts 81,371 A3 Payments BankCharges 278 ReeltimeEvents 1,956 Travelawards & prizes 1,327 MedicalStudentEssayPrizeAccom. Expenses 323 Accommodation/ Subsitence 4,677 Room hire / catering/ organisation 36,139 Accom, subsistence, travel, registration 4,677 Payment to CancerGenetics Group 30,122 Conference Gifts /Extras 1,243 Admin&Running Costs paids toRSB 17,004 Sub total 97,747 Unrestricted funds to the nearest £ Sub total(Gross income for AR) A2 Asset and investment sales, (see table).		to the nearest £ Restricted funds	Endowmen t funds to the nearest £	Total funds Last year to the nearest £ to the nearest £
				730 62,570

				8,866
				765
				8,440



				81,371	56,315





				81,371	56,315

BankCharges	278			278
ReeltimeEvents	1,956			1,956
Travelawards & prizes	1,327			1,327
MedicalStudentEssayPrizeAccom. Expenses	323			323
Accommodation/ Subsitence	4,677			4,677
Room hire / catering/ organisation	36,139			36,139
Accom, subsistence, travel, registration	4,677			4,677
Payment to CancerGenetics Group	30,122			30,122
Conference Gifts /Extras	1,243			1,243
Admin&Running Costs paids toRSB	17,004			17,004
Sub total	97,747			97,747	24,071

A4 Asset and investment purchases,
(see table)


Sub total	97,747	97,747	24,071

Total payments	97,747	97,747	24,071

Net of receipts/(payments) -	16,376	- 16,376	32,244
A5 Transfers between funds
A6 Cash funds last year end	97,887	97,887	65,643
Cash funds this year end	81,511	81,511	97,887

Section B Statement of assets and liabilities at the end of the period

to nearest £ 81,511 81,511 OK to nearest £ Unrestricte d funds Unrestricte d funds Fund to which asset belongs Fund to which asset belongs Fund to which liability relates	to nearest £ to nearest £ Restricted funds Endowment funds	to nearest £ to nearest £ Restricted funds Endowment funds





	to nearest £ to nearest £ Restricted funds Endowment funds






	Cost (optional) Current value (optional)





	Cost (optional) Current value (optional)









	Amount due (optional) When due (optional)






Print Name Date of approval
Ian Ellis		28th March 2025

CHARITY COMMISSION FOR ENGLAND AND WALES Independent examiner's report on the accounts Section A Independent Examiner s Report Report to the trusteesl ClinKal GenelTh ScrEty On accounts for the year | 31. Decwth 2024 Charity no lifany)'2 74 9&9 Sèt out on pages One and two I re[ to the trustees on 6xaTrnatM of the accounts ofthe above chty Trusf) for the year ended 31. De(xnber 2024. Re8pon8ibllities and basls of roport As the charty trustees of the Tfust. you are reSk$Ib fof the preparation of the ac£ounts in accordan wrth the requiremerts ofthe Charities Act 2011 fthe Acr) I rewt in respect of my examinatkn ofthe Tn8 wjunts camed out under SectTr 145 of the 2011 Acl and in carrying out frry examination, I have foll¢ywed the app1Kab DirectirS gi¥en by the Charty Commisslon under secth)n 14515Mbl of the Act. I have completed my exami. I confirm that no material matters have come to my attentson l in connection wrth the examinaon whth gN8s me cause to beIve that In. ary material Independent examlneVs statement accounting records were nck kept in acoydance with 8ectK)n 130 of the Act or the accounts do not )rd with the attounting rrdS I have no concwns and have come a(ms8 no olher matters in connecth)n wrth Ihe examinalM)n to whh attention should be drawn in (der to enabEe a proper understanding ofthe &counts to be 8¢he. ' Ple8se delete the words in the bretS rflhey do nol appty. Signed: J14 2V. March 2025 Rd. Akn K crnents Rtlwant wofessional qualificatlorfs) or body (if any): Associth of Charity Inknndent Exarniners Addrfr3$: 15 Carlth R(>ad, Great KTh*. Chorf8y PR6 8TQ IER October 2018